Ineffectiveness of Intermittent Hemodialysis in a Critically Ill COVID-19 Patient: A Case of Persistent Heparin-Induced Hyperkalemia

Table 1

Summary of laboratory evaluations and relevant trend during hospitalization.

Date	Reference	July 7, 2021	July 9, 2021	July 10, 2021	July 12, 2021	July 14, 2021	July 17, 2021	July18, 2021	July 19, 2021	July 20,2021	July 21,2021	July 22, 2021	July 23, 2021	July 24, 2021	July 25, 2021	July 26,2021
Arterial pH	7.35–7.45	7.62	7.45	7.50	7.50	7.45	7.5	7.41	7.44	7.29	7.33	7.36	7.37	7.38	7.35	7.16
pCO2 (mmHg)	35–45	27.4	47.8	49.7	43.3	43	27	44.7	52.9	61.3	53	48	83	84	88	63
HCO3 (mmol/L)	22–32	27.4	33.7	39.4	33.8	30.6	27	28	32.8	24.9	25	28	28	26	26	25.8
Hemoglobin (g/dl)	12.5–15			15.9		16.3	14.8	14.4		14.3		13.6				12.0
White blood cell count (elements/mm^3)	4,000–10,000	13870		13080		14940	24370	18100		18.500		25.570				27.150
Glycated hemoglobin (%)	4–5.6	7.1
Fibrinogen (g/L)	2–4	5.5
D-dimer (ng/mL)	220–500	˃10000			1224.2
Procalcitonin (ng/mL)	˂0.15	0.18		0.25	0.17	0.10	0.28			0.74			0.41			0.98
CRP (mg/L)	˂6	147		66	41	23	105			297			71			132
Blood urea (mmol/L)	2.5–7.5	10.6			14	14.3	18.6	19.5	14.9	19.8	26.4		25.8			20.3
Serum creatinine (μmol/L)	53–120	69			95	75	126	123	94	170	292		336			290
Sodium (mmol/L)	135–145	129	139	138	139	131	129	134		134	136	134	135	135	134	137
Potassium (mmol/L)	3.0–5.0	4	4.5	4.8	4.7	4.8	4.2	4.5		5.1	6.6	6.4	6.0	6.0	6.4	5.9
Ionized calcium (mmol/L)	1.15–1.30	1.09			1.20
Aspartate amino transferase (UI/L)	6–34	32									45
Alanin amino transferase (UI/L)	8–38	29									41
Uric acid (μmol/L)	150–420	320									332
Phosphorus (mmol/L)	0.97–1.45	1.10									1.7
LDH (UI/L)	140–280	936				674	450				441
CK (UI/L)	22–198	101					97				82
Troponin (Abbot) (ng/mL)	0–0.4	258.3	138.2
Brain natriuretic peptide (pg/mL)	˂300	2071	770			2179	4334	3232	1040	1027	2169
PCR-COVID-19		+				—										—
Antigen/IgG COVID-19		—
Antigen/IgM COVID-19		+

Day of intubation. Start of hemodialysis.